Effects of IL-1β and IL-6 on tissue-type plasminogen activator expression in vascular endothelial cells

Introduction: The increased risk of thrombus formation in inflammatory conditions is generally considered to be due to the pro-coagulant effect of inflammatory cytokines. However, cytokines may also decrease the expression of the key fibrinolytic enzyme tissue-type plasminogen activator (t-PA) causing a reduced clearance of emerging intravascular thrombi. This study investigated the effects of the inflammatory cytokines interleukin (IL)-1 beta and IL-6 on t-PA gene and protein expression, and elucidated by which signaling mechanisms the effects are mediated. Materials and Methods: Cultured human umbilical vein endothelial cells (HUVEC) were exposed to recombinant IL-1 beta or IL-6. t-PA mRNA was quantified by real-time RT-PCR and t-PA antigen by ELISA. To clarify signaling mechanisms, selective inhibitors of major cytokine-activated signaling pathways were used. Interactions of nuclear proteins with potential t-PA gene regulatory elements were studied by get shift assays. Results: Already at low concentrations, IL-1 beta caused a distinct suppression of t-PA transcript and protein levels, mediated primarily by NF-kappa B signaling. This cytokine also increased binding of NF-kappa B subunits to a t-PA specific kappa B element. IL-6 stimulation per se did not affect t-PA mRNA or protein levels whereas soluble IL-6 receptor, in the presence of enclogenous IL-6, suppressed t-PA expression. Conclusions: We conclude that the proinflammatory cytokine IL-1 beta impairs fibrinolytic capacity in vascular endothelial cells by an NF-kappa B dependent suppression of t-PA expression. In contrast, an effect of IL-6 on t-PA expression could not be detected, probably due to tack of IL-6 receptor expression on HUVEC. (c) 2008 Published by Elsevier Ltd.